Develop and evaluate efficacy of nanoformulated siBeclin1 delivered intranasally to eliminate HIV in brain Grant

Develop and evaluate efficacy of nanoformulated siBeclin1 delivered intranasally to eliminate HIV in brain .

date/time interval

  • March 13, 2019 - February 28, 2022

awarded by

administered by

sponsor award ID

  • 1R21MH118985-01

contributor